NDC 0228-2851 – Guanfacine
Guanfacine Hydrochloride 2 mg/1 · Tablet, Extended Release · Oral
Product NDC0228-2851
Product details
- Brand name
- Guanfacine
- Generic name
- Guanfacine
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA200881
- Marketed since
- December 1, 2014
- Marketing end
- January 31, 2027
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Guanfacine Hydrochloride 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0228-2851-11 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2851-11) | Dec 1, 2014 |
Other Guanfacine products
- 50090-7644 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7129 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 0228-2850 Guanfacine Hydrochloride 1 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0228-2853 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0228-2855 Guanfacine Hydrochloride 4 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 72888-226 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-224 Guanfacine Hydrochloride 1 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-225 Guanfacine Hydrochloride 2 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-227 Guanfacine Hydrochloride 4 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 62332-745 Guanfacine Hydrochloride 1 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-747 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-748 Guanfacine Hydrochloride 4 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.